Test Price
2,800 AED✅ Home Collection Available
PLS3 Gene Osteoporosis Susceptibility Genetic Test (NGS) in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS processing and multi-point validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test result interpretation by a DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification and pre-approval via WhatsApp at +971 54 548 8731.
- Price: 2,800 AED | Turnaround Time: 3 to 4 Weeks
Test Overview & Methodology
The PLS3 Gene NGS test is a comprehensive genetic analysis that detects pathogenic and likely pathogenic variants in the plastin 3 (PLS3) gene, the principal cause of X-linked osteoporosis and a key quantitative trait locus (QTL18) for bone mineral density. This test empowers early intervention and personalised treatment plans for at-risk individuals.
| Feature | Our Test – PLS3 NGS | Standard DEXA Bone Scan |
|---|---|---|
| Methodology | Next-Generation Sequencing (Illumina) | Dual-Energy X-ray Absorptiometry |
| Diagnostic Window | Pre-clinical – identifies genetic risk decades before bone loss | Detects existing bone mass deficit only |
| Turnaround Time | 3 to 4 Weeks | Same-day imaging |
| Clinical Utility | X-linked osteoporosis sub-classification, family cascade screening | Quantifies current bone density |
Physician Insight & Safety Protocols
“This genetic test is a powerful tool for unveiling the hereditary predisposition to severe osteoporosis, but it must always be correlated with clinical history, family pedigree, and bone densitometry. A negative result does not rule out other genetic or acquired causes of low bone mass, and a positive finding demands a comprehensive management plan including vitamin D optimisation and possibly specialist referral.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠ Medication Advisory
Maintain your prescribed therapy (e.g., bisphosphonates, denosumab, calcium/vitamin D supplements) unless explicitly instructed otherwise by your treating physician. Premature cessation may precipitate accelerated bone mineral density loss and heighten fracture risk. This genetic risk assessment is designed to complement, not replace, your established treatment plan.
Safety Exclusion Criteria
- Individuals with acute febrile illness or active infection (should postpone phlebotomy).
- Patients with known major bleeding disorders without prior haematologist clearance.
- Children below 18 years unless accompanied by a legal guardian and with a referral from a paediatric endocrinologist.
- Pregnancy is not a contraindication, but genetic testing during pregnancy must be counseled by a prenatal genetics specialist.
🚨 Emergency Red Flags – Seek Immediate Medical Attention If You Experience:
- Sudden severe back pain, loss of height, or acute immobility (possible vertebral fracture).
- Any signs of spinal cord compression (numbness, weakness in legs, bladder/bowel incontinence).
Patient FAQ & Clinical Guidance
1. What exactly does the PLS3 gene test detect, and how is it different from a regular bone density scan?
This advanced NGS test identifies pathogenic variants in the PLS3 gene linked to X-linked osteoporosis and bone mineral density QTL18, enabling precise risk stratification. Unlike a DEXA scan that only measures current bone density, our genetic analysis reveals inherited susceptibility decades before any bone weakening occurs, allowing early preventive interventions tailored to your genetic profile.
2. If my result comes back positive for a PLS3 mutation, does that mean I will definitely develop osteoporosis?
A positive PLS3 result indicates a significantly elevated genetic risk for early-onset osteoporosis, but penetrance is variable and influenced by nutrition, hormones, and lifestyle. It is not a deterministic diagnosis. With proactive management including calcium and vitamin D optimisation, weight-bearing exercise, and periodic DEXA monitoring, the progression can often be slowed or prevented. Clinical genetic counselling will help you interpret the exact risk and plan surveillance.
3. What sample is required, and how is my genetic data protected under UAE law?
We accept a simple blood draw, extracted DNA, or a single drop of blood on an FTA card, all processed under strict ISO 9001:2015 conditions. Your sample is coded, and results are disclosed only to you or your authorised physician. Compliance with the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 guarantees that your genomic information is never shared with third parties without explicit consent. All data is encrypted and stored on locally hosted servers.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143. We strictly comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored on secure local servers, and processed with explicit patient consent. Clinical safety and reporting adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | PLS3 Gene Osteoporosis Susceptibility Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Next-Generation Sequencing (Illumina) |
| ICD-10-CM Code | Z13.820 (Screening for osteoporosis), M81.8 (Other osteoporosis) |
| LOINC Code | 94232-4 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians